- Home
- SPRB vs FLGC Comparison
SPRB vs FLGC Comparison
Compare SPRB & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRB
- FLGC
- Stock Information
- Founded
- SPRB 2014
- FLGC 2019
- Country
- SPRB United States
- FLGC United States
- Employees
- SPRB N/A
- FLGC N/A
- Industry
- SPRB Medicinal Chemicals and Botanical Products
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- SPRB Health Care
- FLGC Health Care
- Exchange
- SPRB Nasdaq
- FLGC Nasdaq
- Market Cap
- SPRB 22.8M
- FLGC 26.5M
- IPO Year
- SPRB 2020
- FLGC 2021
- Fundamental
- Price
- SPRB $0.52
- FLGC $1.27
- Analyst Decision
- SPRB Hold
- FLGC Strong Buy
- Analyst Count
- SPRB 7
- FLGC 3
- Target Price
- SPRB $2.50
- FLGC $6.50
- AVG Volume (30 Days)
- SPRB 400.8K
- FLGC 533.4K
- Earning Date
- SPRB 11-11-2024
- FLGC 11-13-2024
- Dividend Yield
- SPRB N/A
- FLGC N/A
- EPS Growth
- SPRB N/A
- FLGC N/A
- EPS
- SPRB N/A
- FLGC N/A
- Revenue
- SPRB $7,101,000.00
- FLGC $69,006,000.00
- Revenue This Year
- SPRB N/A
- FLGC N/A
- Revenue Next Year
- SPRB N/A
- FLGC $19.90
- P/E Ratio
- SPRB N/A
- FLGC N/A
- Revenue Growth
- SPRB N/A
- FLGC 13.06
- 52 Week Low
- SPRB $0.41
- FLGC $0.70
- 52 Week High
- SPRB $5.95
- FLGC $2.93
- Technical
- Relative Strength Index (RSI)
- SPRB 47.26
- FLGC 42.50
- Support Level
- SPRB $0.51
- FLGC $1.11
- Resistance Level
- SPRB $0.56
- FLGC $1.63
- Average True Range (ATR)
- SPRB 0.03
- FLGC 0.17
- MACD
- SPRB -0.01
- FLGC -0.05
- Stochastic Oscillator
- SPRB 16.61
- FLGC 14.43
About SPRB Spruce Biosciences Inc.
Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH).
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.